Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Jazz Pharmaceuticals

Jazz Pharmaceuticals

A biopharmaceutical company engaged in the discovery, development and commercializing of pharmaceutical products

Jazz Pharmaceuticals is a biopharmaceutical company that is dedicated to bringing life-changing medicines to the people who have limited or no options, so they can fully live their lives. The company focuses on developing medicines for people living with serious diseases, often presented with limited or no options, so they can fully live their lives.

The company is working to give people the opportunity to redefine what is possible to make the “small wins” big again, by transforming biopharmaceutical discoveries into novel medicines.

It is an integrated growing biopharmaceutical company that has a diverse portfolio of marketed medicines and novel product candidates in two key therapeutic areas: neuroscience and oncology. The company is an industry leader in epilepsy and sleeping disorders, and Jazz is growing its presence in oncology in hematologic malignancies and solid tumors.

Across its commercial franchises and development programs, Jazz Pharmaceuticals focuses on innovative therapies and support for adults and children living with these conditions. The company explores new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies.


February 16, 2021
Jazz Pharmaceuticals announces the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration seeking marketing approval for XywavTM (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of adult patients with idiopathic hypersomnia.
February 3, 2021
Jazz Pharmaceuticals will acquire CBD drugmaker GW Pharma for $7.2 billion




Further Resources



Jazz Pharmaceuticals plc
June 17, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW)...
DelveInsight Business Research, LLP
June 14, 2021
/PRNewswire/ -- DelveInsight's "Epilepsy Market" report provides a thorough comprehension of the Epilepsy historical and forecasted epidemiology and the...
June 14, 2021
Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer Community - read this article along with other careers information, tips and advice on BioSpace
Jazz Pharmaceuticals plc
June 14, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the launch of Nothing Small About It (, an online program...
Jazz Pharmaceuticals plc
June 9, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from...


Golden logo
By using this site, you agree to our Terms & Conditions.